结直肠癌治疗的医院费用。
Hospital costs of colorectal cancer care.
作者信息
Macafee D A L, West J, Scholefield J H, Whynes D K
机构信息
Division of GI Surgery, Queen's Medical Centre, Nottingham.
出版信息
Clin Med Oncol. 2009 Mar 20;3:27-37. doi: 10.4137/cmo.s2362.
OBJECTIVE
In a hospital based setting, identify factors which influence the cost of colorectal cancer care?
DESIGN
Retrospective case note review
SETTING
Nottingham, United Kingdom
PARTICIPANTS
227 patients treated for colorectal cancer
METHODS
Retrospective review of the hospital records provided the primary data for the costing study and included all CRC related resource consumption over the study period.
RESULTS
Of 700 people identified, 227 (32%) sets of hospital notes were reviewed. The median age of the study group was 70.3 (IQR 11.3) years and there were 128 (56%) males. At two years, there was a significant difference in costs between Dukes D cancers ( pound3641) and the other stages ( pound3776 Dukes A; pound4921 Dukes B). Using univariate and multivariate regression, the year of diagnosis, Dukes stage of disease, intensive nursing care, stoma requirements and recurrent disease all significantly affected the total cost of care.
CONCLUSIONS
CRC remains costly with no significant difference in costs if diagnosed before compared to after 1992. Very early and very late stage cancers remain the least costly stage of cancers to treat. Other significant effectors of hospital costs were the site of cancer (rectal), intensive nursing care, recurrent disease and the need for a stoma.
目的
在医院环境中，确定影响结直肠癌治疗费用的因素？
设计
回顾性病例记录审查
地点
英国诺丁汉
参与者
227例接受结直肠癌治疗的患者
方法
对医院记录进行回顾性审查，为成本研究提供主要数据，包括研究期间所有与结直肠癌相关的资源消耗。
结果
在确定的700人中，审查了227份（32%）医院记录。研究组的中位年龄为70.3岁（四分位间距11.3），男性有128人（56%）。两年时，Dukes D期癌症（3641英镑）与其他分期（Dukes A期3776英镑；Dukes B期4921英镑）的费用存在显著差异。使用单变量和多变量回归分析，诊断年份、疾病的Dukes分期、重症护理、造口需求和复发性疾病均对总治疗费用有显著影响。
结论
结直肠癌治疗成本仍然很高，1992年之前或之后诊断的成本没有显著差异。极早期和极晚期癌症仍然是治疗成本最低的癌症阶段。医院成本的其他重要影响因素是癌症部位（直肠）、重症护理、复发性疾病和造口需求。
Zotero 插件